G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse ...

Scientists have unlocked new details on important receptor proteins—promising targets for the creation of novel drugs for metabolic conditions ranging from diabetes to obesity and inflammatory ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

Announcing a new article publication for BIO Integration journal. Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019 Potential to further expand Viking's treatment options for weight loss ...

Researchers created a tool capable of comprehensively mapping crucial interactions underlying drug efficacy in one superfamily of cell receptors. One in every three FDA-approved drugs targets a single ...

However, the measurement of sIL-2R is simple compared to the complex story behind this biomarker that has become so central to the study of immune-mediated disease. Why measure soluble interleukin-2 ...

•Oral selective estrogen receptor degraders are in multiple clinical trials with the potential to become a future mainstay of endocrine therapy. •Late relapse remains a key challenge of treating ...

Serotonin receptor agonists are a group of medications that activate the serotonin receptors in the central nervous system. A low serotonin level can lead to difficulty sleeping, depression, anxiety, ...

Opioids slot into opioid receptors and activate them. This sends signals to your brain to relieve pain and promote pleasure. Both endogenous opioids, which your body naturally produces, and exogenous ...